Clinical Trials Sponsored by Istituto Toscano Tumori

Total 533 results

Cancer Prevention and Research Institute, Italy
Istituto Toscano Tumori

Unknown

Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women

Cervical Cancer

Italy
Fondazione Sandro Pitigliani
Genomic Health®, Inc.; Istituto Toscano Tumori

Active, not recruiting

Probability of OncotypeDx to Reallocate as Low or High Risk of Recurrence Breast Cancer Patients With Uncertain Biology

Breast Cancer

Italy
Cancer Prevention and Research Institute, Italy
University of Florence; Istituto Toscano Tumori

Completed

Effect of HPV Vaccination on Women Aged 25 Years

Cervical Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Istituto Toscano Tumori; Temas srl; Clirest s.r.l.; Mipharm S.p.A.

Unknown

Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC (Nabster)

Small Cell Lung Cancer

Italy
Tuscan Dental Institute

Completed

mp3 vs Apatos in Post-extractive Sockets

Alveolar Bone Loss
Gruppo Oncologico Italiano di Ricerca Clinica
Bioikos Ambiente Srl; Istituto Toscano Tumori; Temas srl; Mipharm S.p.A.; Bristol...

Active, not recruiting

Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial) (EDEN)

Squamous Non-small Cell Lung Cancer

Italy
Tuscan Dental Institute

Completed

Slow-release Locally Administered 0.02% Hypochlorite Formulation

Periodontal Diseases

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project (Eternity)

Cervical Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC) (ProphyPIPAC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

A Retrospective Study on Multiple Classifier Endometrial Cancer

Uterine Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

The ImmunoXXL Study (ImmunoXXL)

Hepatocellular Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Metastatic Clear Cell Renal Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (Agility)

Melanoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer (CATARTIC)

Rectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease (PCRSS)

Advanced Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET (LOLA)

Neuroendocrine Tumors | Metastatic Well Differentiated Neuroendocrine Neoplasm

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice

Neoplasms | Quality of Life | Psychological Distress | Symptoms and Signs | Satisfaction, Consumer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" (ARCADIA)

Bladder Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Radiomics and Machine Learning in the Diagnosis of Ovarian Masses (Multi-AROMA)

Ovarian Cysts | Ovarian Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

Metastatic Urothelial Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Metastatic Sporadic Medullary Thyroid Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients (CAPTEM)

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Terminated

A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia (DATA)

Neuromuscular Blockade

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

caBozantinib in cOllectiNg ductS Renal Cell cArcInoma (BONSAI)

Collecting Duct Carcinoma (Kidney)

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Withdrawn

Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study (PECULIAR)

Muscle-invasive Bladder Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) (CaboPen)

Penile Squamous Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. (TOCANNATO)

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb (PIPELINE)

Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 (ACC-LEN14)

Adenoid Cystic Carcinomas of the Salivary Glands

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Transitional Cell Carcinoma | Bladder Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Nutritional Status in Retroperitoneal Sarcoma. (NOVA)

Malnutrition | Retroperitoneal Sarcoma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Cancer Anesthesia and Frailty

Cancer | Anesthesia | Fragility

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Terminated

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) (TOKIO)

Renal Cancer Cell

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)

Multiple Myeloma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Skin Squamous Cell Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

TARC After alloSCT in Hodgkin's Lymphoma (TARC)

Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prospective Observational Study on Plerixafor After Chemotherapy

Lymphoma | Myeloma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without Stoma

Rectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) (PANDORA)

Merkel Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC) (OrganoHIPEC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Treatments of HPV-related Lesions

Cervical Cancer | HPV | Cervix Lesion | Vagina Disease
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy ((GreenEye-CRC))

Rectal Cancer | Lymph Node Cancer Metastatic

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy (Serpentine)

Melanoma | Renal Cell Carcinoma | Breast Cancer | NSCLC | Urinary Bladder Cancer | Squamous Cell Carcinoma of Head and Neck | Small Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients (ACAPP)

Pseudomyxoma Peritonei

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients (WIN-HYPO2021)

Hypothyroidism; Irradiation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer (LIQUID)

Gastric Cancer | Gastric Adenocarcinoma

Italy

Clinical Trials Sponsored by Istituto Toscano Tumori

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations